https://pittplusme.org/study/1804
ACTIV-2 COVID-19 Research Study
This study is not currently recruiting. Please check back at a later time.
STUDY BASICS
Did you test positive for COVID-19 within the past 7 days? Are you currently experiencing some symptoms of illness? You may be able to participate in a study that is evaluating the ability of various experimental medications to improve health outcomes for people with COVID-19. Participation involves up to 8 planned visits over 24 weeks. Compensation is provided.
IRB: SSU00128064
- National Institute of Allergy and Infectious Diseases - ACTIV-2/A5401, Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID) (Pro00045266)
AGE:
18 and up
DURATION:
6 months
VISITS:
Up to 8 planned visits
LOCATION:
Kaufmann Medical Building - Oakland
COMPENSATION:
Yes
SHARE STUDY
MEET THE RESEARCHER
Madhu Choudhary
Madhu Choudhary is an Associate Professor in the Division of Infectious Diseases in the Department of Medicine at the University of Pittsburgh. A graduate of Maulana Azad Medical College, Dr. Choudhary’s research interests include HIV and viral hepatitis therapeutic clinical trials.